Oxycodone
OXAYDO, OxyContin, Oxycodone Hydrochloride, Roxicodone, RoxyBond, XTAMPZA
Opioid Agonist
NADAC/unit
$0.0447
No Shortage
Tier 1: 193.9%
PA Req: 77.2%
18 Manufacturers
67 ANDAs
Oxycodone relieves moderate to severe pain by acting on opioid receptors in the brain.
vs. brand OXAYDO: Generic saves up to 100% per unit
Active Shortages
2025-09-11 Hikma has permanently discontinued (NDC 0054-0390-41) for the 15 mL bottle configuration. Hikma will continue to distribute Oxycodone Hydrochloride Oral Solution 5 mg/5 mL in the 500 mL bottle (NDC 0054-0390-63)., Hikma Pharmaceuticals USA, Inc.
Market Intelligence
2026-02-18 Class II Recall: Amerisource Health Services LLC
2023-11-15 Class III Recall: Zyla Life Sciences US Inc.
Generic Manufacturers
ABHAI LLCALKEM LABORATORIES LTDALVOGEN INCAMNEAL PHARMACEUTICALSANI PHARMACEUTICALS INCASCENT PHARMACEUTICALS INCAUROLIFE PHARMA LLCAVANTHI INCCOLLEGIUM PHARMACEUTICAL INCEPIC PHARMA LLCGENUS LIFE SCIENCES INCHIBROW HEALTHCARE PRIVATE LTDHIKMA PHARMACEUTICALS USA INCNOVEL LABORATORIES INCNUVO PHARMACEUTICAL INCPHARMACEUTICAL ASSOCIATES INCPROTEGA PHARMACEUTICALS INCPURDUE PHARMA LPQUAGEN PHARMACEUTICALS LLCRHODES PHARMACEUTICALS LPSPECGX LLCSTRIDES PHARMA INTERNATIONAL AG
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.